Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Neuroblastoma 2Carcinoma, Renal Cell 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Sarcoma, Clear Cell 1Rhabdoid Tumor 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Malignant Liver Neoplasm 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1

Interventions

Gemcitabine 31Cisplatin 21pembrolizumab 8Fluorouracil 6Oxaliplatin 5Capecitabine 5130-nm albumin-bound paclitaxel 5durvalumab 4Taxes 4Albumin-Bound Paclitaxel 4pemigatinib 3infigratinib 3atezolizumab 3Specimen Handling 3Radiosurgery 3Platinum 3Magnetic Resonance Spectroscopy 3Leucovorin 3Carboplatin 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2trametinib 2olaparib 2ivosidenib 2derazantinib 2cobimetinib 2Trastuzumab 2Radiotherapy 2Panitumumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cholangiocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT02200042 2026-05-19

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

NRG Oncology

Phase 3 Terminated
1 enrolled 5 charts
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡